Marketers and finance people seldom see eye to eye. The makers say, “This product will open up a whole new market segment.” Finance people respond, “It’s a bad investment. The IRR is only 8%.” Why are they so often in opposition?
A version of this article appeared in the September–October 1989 issue of Harvard Business Review.